107 related articles for article (PubMed ID: 12355837)
1. [Transgenic mouse model of type 1 diabetes mellitus].
Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():70-4. PubMed ID: 12355837
[No Abstract] [Full Text] [Related]
2. [An animal model of type 1 diabetes (NOD mice)].
Nagata M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():25-32. PubMed ID: 12355754
[No Abstract] [Full Text] [Related]
3. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
4. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
[No Abstract] [Full Text] [Related]
5. [Knockout mouse in the research of type 1 diabetes].
Tamemoto H
Nihon Rinsho; 2002 Aug; 60 Suppl 8():52-7. PubMed ID: 12355801
[No Abstract] [Full Text] [Related]
6. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy for diabetes].
Moritani M; Itakura M
Nihon Rinsho; 1997 Nov; 55 Suppl():739-45. PubMed ID: 9434557
[No Abstract] [Full Text] [Related]
9. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
10. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models.
Grewal IS; Flavell RA
Lab Invest; 1997 Jan; 76(1):3-10. PubMed ID: 9010445
[No Abstract] [Full Text] [Related]
11. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes.
Bradley LM; Asensio VC; Schioetz LK; Harbertson J; Krahl T; Patstone G; Woolf N; Campbell IL; Sarvetnick N
J Immunol; 1999 Mar; 162(5):2511-20. PubMed ID: 10072490
[TBL] [Abstract][Full Text] [Related]
12. [NOD mouse (non-obese diabetic mouse)].
Moriyama H; Nagata M; Yokono K
Nihon Rinsho; 1998 Jan; 56 Suppl 3():688-94. PubMed ID: 9513497
[No Abstract] [Full Text] [Related]
13. The role of innate immunity in autoimmunity.
Bach JF; Bendelac A; Brenner MB; Cantor H; De Libero G; Kronenberg M; Lanier LL; Raulet DH; Shlomchik MJ; von Herrath MG
J Exp Med; 2004 Dec; 200(12):1527-31. PubMed ID: 15611284
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
Martin S; Hibino T; Faust A; Kleemann R; Kolb H
J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of virus-induced autoimmune diabetes: novel insights gained from the RIP-LCMV transgenic mouse model.
von Herrath MG; Homann D; Gairin JE; Oldstone MB
Biochem Soc Trans; 1997 May; 25(2):630-5. PubMed ID: 9191170
[No Abstract] [Full Text] [Related]
16. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
Heurtier AH; Boitard C
Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms of beta-cell destruction in type 1 diabetes].
Mandrup-Poulsen TR
Ugeskr Laeger; 2001 Aug; 163(32):4176-9. PubMed ID: 11510233
[No Abstract] [Full Text] [Related]
19. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant.
Hartmann B; Bellmann K; Ghiea I; Kleemann R; Kolb H
Diabetologia; 1997 Aug; 40(8):902-9. PubMed ID: 9267984
[TBL] [Abstract][Full Text] [Related]
20. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
